Growth response of steer calves treated with zeranol, oestradiol 17β or progesterone-oestradiol benzoate implants before and after weaning

This experiment compared the growth response of untreated steer calves with those given a long acting oestradiol-silicone rubber implant or implants of zeranol or oestradiol-progesterone pellets either singly, or repeated after 79 days. The experiment extended through the 6 weeks prior to weaning at 8 months of age, 5 weeks of grazing oat stubble and a 16-week finishing phase on a feedlot. The oestradiol-silicone rubber implant was the only product to significantly increase weight gains compared to controls (0.69 vs 0.52 kg/head/day, 18.2% advantage) in the pre-weaning phase. All anabolic agents produced higher weight gains ranging from increases of 0.16 to 0.19 kg/head/day (18.2-21.6%) above controls in the first 60 days of the feedlot phase. Responses did not differ significantly among the products and were the same whether or not steers had been previously implanted. Lower planes of nutrition in the late suckling and post-weaning periods were accompanied by smaller and non-significant responses to both the short acting anabolics, zeranol and oestrogen-progesterone, compared to the increased weight gains of steers given oestradiol-silicone rubber implants. Implanting with oestradiol in a silicone rubber matrix resulted in similar increases in weight gain both before and during the feedlot phase. This may have been due to the implant maintaining a continuously high level of circulating anabolic agent for the 190 days of the experiment.     

Sexual development in beef bulls following zeranol implants

Two trials were conducted to study the effect of zeranol implants on growth and sexual development of bull calves. Trial 1 compared the effects of implanting with 72 mg of zeranol at 48 d of age (branding), at 215 d of age, or at both times with nonimplanted control bulls. Implanting at branding resulted in decreased scrotal circumference, testicle weight and proportion of bulls that could produce an ejaculate at 14 mo of age (P less than .01). Implanting at 215 d of age had no effect on any of these traits. Growth rate was not increased by implanting at either time but was decreased (P less than .02) in animals implanted at both times when compared with control bulls. In trial 2, both bulls and steers were implanted with zeranol and compared with nonimplanted control bulls and steers. Thirty-six-milligram implants were given at 21, 103, 260 and 343 d of age. Scrotal circumference, testicle weight and serum testosterone concentrations decreased (P less than .01) and the occurrence of penis abnormalities increased (P less than .01) in implanted bulls compared with control bulls. By the time of slaughter, however, testosterone concentrations were equal in control and implanted bulls; and the difference in scrotal circumference was diminishing. This is interpreted as evidence that as the bulls get older, they can overcome the effect of the implants. Carcass weights were heavier in implanted steers than in control steers but were lighter in implanted bulls than in control bulls (P less than .02). Carcasses of implanted bulls had higher quality scores and more marbling than control bulls, but carcasses of implanted steers had lower quality scores and less marbling than control steers (both interactions, P less than .01). Implanting bulls with zeranol at an early age resulted in restricted sexual development but not in total sterility. Repeated zeranol implants throughout the growing and finishing phase enhanced carcass quality in bulls slaughtered at 14 to 16 mo of age.     

The effects of zeranol on growth and fattening in beef calves before weaning

Four-month-old beef calves were implanted with 36 mg zeranol, and their growth compared with untreated calves. Treated steer and heifer calves gained 10 kg more bodyweight to weaning at 7.5 months of age. The trial was conducted at 2 research centres and calves at both centres showed significant responses for the first 45 days (P less than 0.001) after treatment but during the following 30 days only calves at one centre showed a continued response (P less than 0.05). No differences in growth rate occurred between treated and untreated calves over the final 30 days before weaning at either centre. The backfat measurement of untreated animals increased more than that of the implanted animals (P less than 0.05) at one centre but not at the other.     

The effect of time of implanting zeranol on the growth of suckling steer calves

Three groups of beef steer calves were implanted in 1983 with 36 mg of zeranol at 2 months or 4.5 months age or at both these ages, and their growth rates were compared with an untreated group. At approximately 8 months age in December the 3 implanted groups were heavier than the control group by 14.6 kg (P less than 0.05), 23.4 kg and 22.1 kg (P less than 0.01). At peak animal weights recorded in March the differences were 18.7 kg (P less than 0.05), 31.3 kg and 31.0 kg (P less than 0.01). In June 1984, following loss of weight by the steers, differences between the implanted groups and the control groups had declined to 7.7 kg (P greater than 0.05), 19.4 kg (P less than 0.01) and 21.1 kg (P less than 0.001), differences similar to those recorded approximately 3 months after implantation. It is concluded that higher weight gains resulted from implanting suckling calves at 4.5 months of age, than by implanting calves at 2 months of age, and that implanting suckling calves twice is unlikely to be any better than implanting them once at 3 to 6 months age. Part of the maximal response can be lost if steers subsequently lose weight.     

Effects of creep feeding, zeranol implants and breed type on beef production: I. Calf and cow performance

A 2-yr study was conducted to evaluate the effects of a high-energy creep feed, preweaning zeranol implants and breed type on calf and cow performance. Two hundred calves sired by Brahman and Romana Red bulls out of Angus and Angus x Brown Swiss reciprocal crossbred (F1) dams were stratified by breed type and sex to three creep treatments: no creep feed (NC); long-term creep (LC), creep-fed from 56 to 210 d of age (weaning); and short-term creep (SC), creep-fed from 146 to 210 d of age. Alternate calves within sex, breed type and creep treatment were implanted with 36 mg of zeranol at an average of 56 d and reimplanted 90 d later. The LC and SC calves had heavier (P less than .001) 210-d weights than NC calves (264 and 257 vs 231 kg, respectively), and the LC calves were heavier (P less than .001) at 146 d than NC calves. The LC calves had higher (P less than .001) ADG from 118 to 210 d of age and higher 146 and 210-d condition scores than did NC calves. Pregnancy rate was not affected (P greater than .46) by creep treatment of calf. Zeranol implants increased (P less than .01) 146- and 210-d weights (184 vs 175 kg and 259 vs 243 kg) and ADG during all periods to weaning. Brahman-sired calves had higher (P less than .005) 146- and 210-d weaning weights and frame scores than Romana Red-sired calves.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of zeranol on protein turnover in L6 myotubes

Protein synthesis and degradation were measured in cultures of L6 myotubes to determine the direct anabolic activity of zeranol on muscle. Zeranol, dexamethasone, insulin and zeranol-dexamethasone combination, at various concentrations from 10(-8) to 10(-6) M, were added to cultures at either 18 hr prior to or at the beginning of a 6 hr synthesis or degradation measuring period. Protein synthesis was measured by determining the incorporation of radioactivity into trichloraoacetic acid precipitable cell protein following incubation with [3H] leucine. Protein synthesis was expressed as cpm incorporated in 6 hr per mg protein. Protein degradation was measured by a pulse-chase procedure using [3H] leucine. Protein degradation was expressed as the percent labeled protein degraded in 6 hr. Results from the study indicate that zeranol did not stimulate protein synthesis or inhibit proteolysis (P greater than .01). Stimulation of proteolysis observed with 10(-8) M dexamethasone was 13% and 18% (P less than .01) at the 6 hr and 24 hr incubation period, respectively. Dexamethasone-stimulated protein degradation was not altered appreciably by zeranol. In contrast, 10(-6) M insulin significantly (P less than .01) stimulated protein synthesis (16%) and inhibited protein degradation (15%). These results suggest that the anabolic action of zeranol does not occur by directly regulating muscle protein synthesis or degradation, or by altering the glucocorticoid-induced catabolic response in muscle.     

Effects of nutrition, sex of calf and breed type on response to zeranol: preweaning growth

An experiment was conducted to evaluate the effects of breed, sex and plane of nutrition on the growth response to zeranol in Angus and crossbred calves prior to weaning. Eighty-eight heifers and 118 steers received either a high or low plane of nutrition using a first and last grazing technique. Half of the calves in each nutrition group received a zeranol implant (36 mg) at an average age of 3.4 mo. Both zeranol and the higher level of nutrition increased (P less than .001) growth rate prior to weaning (7.4 mo of age). Zeranol did not affect hip height at weaning (P greater than .1), but calves on the higher plane of nutrition were taller (P less than .01) than calves on the lower plane of nutrition. The zeranol x nutrition interaction was not significant (P greater than .1) for growth rate or hip height. Steers grew faster (P less than .01) preweaning and were taller (P less than .01) at weaning than heifers. Crossbred calves gained more rapidly (P less than .001) preweaning and were taller (P less than .001) at weaning than Angus calves were. Neither sex nor breed interacted with zeranol to influence any of the traits examined. Based on these results we conclude that preweaning growth was affected by zeranol and this effect was consistent across sexes, breeds and planes of nutrition tested.     

Weight gain in steer and heifer calves treated with zeranol or oestradiol 17 beta

Male and female Hereford and Hereford cross beef calves between 2.5 and 4.5 months of age were implanted with 36 mg zeranol, 24 mg oestradiol 17 beta or left untreated, and then weighed every 4 to 5 weeks. Calves treated with zeranol or oestradiol 17 beta gained 9.6 kg (8.2%) and 12.9 kg (11.0%) more weight respectively than untreated calves. Steer calves gained more weight than heifer calves. There was no response to either growth promotant in heifers or in zeranol-treated steers beyond 35 days after implantation, and the only significant further gains in the next 31 days were made by steers treated with oestradiol 17 beta. After this time growth of treated and control calves was similar. The lack of a continued response to the growth promotants was not associated with significantly lower growth rates in any weighing interval.     

Effects of creep feeding, zeranol implants and breed type on beef production: II. Reproductive development and fat deposition in heifers

Effects of preweaning creep feeding and zeranol implants on reproductive tract development and udder and s.c. fat deposition were studied in 24 weanling heifers (7 mo of age) with Brahman and Romana Red sires and Angus and Angus x Brown Swiss F1 reciprocal crossbred dams. Creep treatment did not affect (P greater than .19) ovarian weight, ovarian size, uterine horn diameter or follicle number. Heifers from the three creep treatments did not differ (P greater than .25) in udder weight, total lipid or percentage of lipid in the udder. Noncreep-fed (NC) heifers had a greater (P less than .02) number of adipocytes/gram of udder tissue than did the long-term creep-fed (LC) and short-term creep-fed (SC) heifers. The LC heifers had larger udder (166.0 vs 152.7 m) and s.c. adipocytes (166.7 vs 148.8 m) than NC heifers. Heifers implanted with zeranol at 56 and 146 d of age had a greater (P less than .03) uterine horn diameter and heavier (P less than .02) uterine weight than unimplanted heifers. Percentage of lipid in the udder was lower (P less than .02) in heifers implanted with zeranol. Implanted heifers had smaller (P less than .10) s.c. adipocytes than unimplanted heifers. Breed of dam did not effect (P greater than .17) development of the reproductive tract of weanling heifers. Heifers from Angus dams had smaller (P less than .08) udders and less (P less than .10) total fat in the udder than those from F1 dams, and the heifers from F1 dams tended (P less than .12) to have larger udder adipocytes.(ABSTRACT TRUNCATED AT 250 WORDS)     

Influence of zeranol implants on growth, behavior and carcass traits in Angus and Limousin bulls and steers

A 2(3) factorial arrangement of treatments was utilized to determine effects of postweaning zeranol implantation, breed (Angus vs Limousin) and castration (bull vs steer) on growth, behavior and carcass traits. An initial slaughter group was used to account for breed differences in composition and to determine fat and lean growth in the 9-10-11th rib section (NTE). The remaining cattle were fed a finishing diet to a fat end point of .76 cm, as determined by a backfat probe. Control bulls outgained (P less than .01) control steers both to the first kill date and over the entire test and did not require significantly more time to reach the fat end point. The implant did not influence gain in bulls but did increase gain in steers. Angus and Limousins were similar in growth rate for the first 126 d before the first slaughter date. Limousins required more (P less than .01) time to reach the fat end point. Bulls and Limousins produced heavier (P less than .01) carcasses and larger rib eyes (P less than .05; bulls; P less than .01; Limousins). Steers and Angus had higher (P less than .01) marbling scores and lower bone maturity. Implanting decreased (P less than .05) marbling and increased carcass maturity. Small but significant shifts in carcass wholesale cut weight distribution were found between breed and sex condition groups. Bulls and Limousins had greater lean growth in the NTE. Bulls and steers were similar in fat growth, but Angus exceeded Limousin in this trait. Zeranol reduced scrotal circumference (P less than .01) and testicle weight at slaughter (P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of haemorrhagic septicaemia vaccination and levamisole administration on the humoral response in cross-bred calves

Levamisole administered by oral, subcutaneous or transdermal routes following vaccination against Pasteurella multocida enhanced the humoral response in cross-bred calves. The group that received levamisole subcutaneously elicited highly significant (P less than 0.01) antibody titres during the primary humoral response in comparison with groups that received levamisole orally or transdermally. During the secondary response in the same experiment, levamisole administered subcutaneously and transdermally showed highly significant (P less than 0.01) haemagglutination titres relative to oral administration of the drug. In a second experiment, the group that received levamisole subcutaneously showed highly significant (P less than 0.01) antibody titres during the anamnestic humoral response over other treated groups.     

The hormonal response in bulls to the administration of zeranol and rumensin

The objective of the study was to investigate the influence of the growth stimulators Ralgro zeranol and Rumensin on changes in concentrations of certain hormones in the blood of beef bulls. In the first experiment 21 bulls were investigated which were divided into three groups. The first group was control, the second was administered the Ralgro stimulator (3X) and the third the Ralgro and Rumensin stimulators. In the second experiment there were 12 bulls. The animals in the test group were implanted Ralgro five times during the fattening period. Alternate changes, mostly insignificant, were recorded between the groups in the concentration of triiodothyronine and cyclic adenosine phosphate. Thyroxine concentrations were reduced during all investigations of the first and second experiments in the animals stimulated by the Ralgro preparation. A significant increase was recorded in the bulls at the age of 14.3 months in the second experiment (62.8 nmol.l-1, in comparison with 56.9 nmol.l-1). In both experiments an identical trend of insulin content was observed--in seven out of the total number of eight observations the animals treated with the Ralgro preparation had statistically insignificantly higher values. The largest differences were recorded at the age of 11.1 and 14.3 months in the second experiment (3.9 microIU.ml-1 and 3.6 microIU.ml-1). Significant differences were observed in testosterone concentrations in the second bulls of the test group were lower by 1.9+ nmol.l-1 and 3.4++ nmol.l-1, respectively.     

Effects of intravenous Escherichia coli dose on the pathophysiological response of colostrum-fed Jersey calves

Objectives of the present study were to characterize the dose dependency of an intravenous Escherichia coli O111:H8 challenge in colostrum-fed Jersey calves and to identify any biochemical markers indicative of septicemia. Eighteen 3-week old colostrum-fed Jersey calves were completely randomized to 1 of 6 doses of E. coli O111:H8. The challenge doses included 0, 1.5 x 10?, 1.5 x 10?, 1.5 x 10?, 1.5 x 10?, and 1.5 x 10? colony-forming units (CFU) given intravenously as a bolus in 5 mL of sterile isotonic saline. Peripheral blood samples were collected at 0, 2, 4, 8, 12, 24, and 48 h relative to the challenge for biochemical, total leukocyte count, and differential analyses. Rectal temperatures were collected via indwelling rectal temperature probes at 5-min intervals, and hourly averages calculated from 2 d prior to the challenge till 2 d after the challenge. All calves survived the 48 h observation period following the challenge. Calves given 1.5 x 10? and 1.5 x 10? CFU displayed sickness behaviors (P < 0.01) beginning 0.5 h after the challenge and returned to that of the control calves by 6 and 32 h for calves challenged with 1.5 x 10? and 1.5 x 10? CFU, respectively. There were treatment x time interactions (P < 0.01) on total leukocyte counts and plasma glucose and zinc concentrations. Calves administered 1.5 x 10? and 1.5 x 10? CFU had leucopenia beginning 2 h after the challenge and returning to counts similar to the control calves within 24 h. Additionally, those calves were hypoglycemic from 4 to 12h after the challenge with the degree of hypoglycemia inversely related to the dose of the E. coli. All calves challenged with E. coli had decreased plasma zinc concentrations, and the magnitude was inversely proportional to the challenge dose. There were treatment x time interactions (P < 0.001) on rectal temperatures following the challenge. All calves challenged with E. coli developed a febrile response, but the intensity and duration of the response were dependent on the challenge dose. These data indicate that calves intravenously challenged with 1.5 x 10? and 1.5 x 10? CFU of the E. coli O111:H8 showed immediate clinical and biochemical signs indicative of septicemia. However, calves administered 1.5 x 10? or less of the E. coli had febrile responses, but did not develop septicemia. Blood glucose and zinc concentrations may be dose responsive indicators that could potentially differentiate between a septicemic versus non-septicemic calf.     

Effects of dihydroheptaprenol on neutrophil functions in calves

Microemulsified dihydroheptaprenol (DHP) was administered intramuscularly to clinically healthy calves at doses of 4, 6 and 8 mg/kg body weight. Marked increase of neutrophil counts was observed 0.5, 1 and 2 days after the injection at a dose of 6 mg/kg. Nitroblue tetrazolium reducing activity of neutrophils was also obviously enhanced 1, 2 and 3 days after DHP administration. Phagocytic killing of Staphylococcus aureus by neutrophils was further enhanced markedly 1, 2 and 3 days after the drug injection at 6 mg/kg.     

The effect of a preassembly zeranol implant and post-transit diet on the health performance and metabolic profile of feeder calves

A total 262 Angus steer calves averaging 207 kg from none (trial 1) and five farms (trial 2) were identified on the farm of origin and one-half of the calves on each farm was implanted with 36 mg of zeranol before entering the feeder calf assembly and marketing system. Calves were assembled, fasted for 24 h and fed hay for 72 h, then shipped 1,368 km. Upon arrival, the following receiving diets were fed for 4 wk to one-third of the calves from each farm and implant group: 1) control diet, 2) high-potassium diet, 3) escape-protein diet using corn gluten meal, which can escape ruminal degradation as a protein source. Implanted calves gained more weight (P less than .10) than nonimplanted calves while on the farm, but changes in weight during assembly, transit and the 28-d receiving period were not different (P more than .10). Plasma glucose and total protein concentrations were higher (P less than .05), while urea nitrogen concentration was lower (P less than .05) for implanted calves following transit. Increasing the potassium concentration of the receiving diet increased (P less than .05) post-transit weight gains, but had no affect on dry matter consumption. Corn gluten meal replaced soybean meal in the escape-protein diet and resulted in similar weight gains. Plasma urea nitrogen concentrations were higher (P less than .05) at 2 wk post-transit in the escape-protein diet group as compared with the control group. Receiving diet had no effect on the incidence or severity of bovine respiratory disease, but affected (P less than .05) performance during the subsequent 69-d stocker phase of ad libitum access to medium quality hay and 2.27 kg of supplement per day.     

Influence of zeranol implants and electrical stimulation on the palatability traits of five muscles in Angus and Limousin bulls and steers

A split-plot design was used to study effects of male status (bull vs steer), zeranol implants, breed types (Angus vs Limousin) and electrical stimulation on palatability traits of five major muscles when all animals were fed to a similar fat-thickness endpoint. Warner-Bratzler shear (WBS) determinations and taste-panel evaluations were performed on the longissimus, adductor, semimembranosus, semitendinosus and biceps femoris muscles removed 24 h postmortem. Breed was the most consistent main effect difference, with Angus cattle having lower WBS values than Limousin for the longissimus and semitendinosus muscles. Angus cattle also were favored in many sensory traits. Few significant differences were noted between bulls and steers in taste-panel traits. Differences due to electrical stimulation were most evident in the longissimus muscle, with higher panel-evaluation scores, an enhancement of marbling and lean color and a lower incidence of heat ring. The implant tended to have negative effects on palatability in this trial. An overall ranking of the five muscles based on WBS from most tender to least tender was: adductor, semimembranosus, longissimus, semitendinosus and biceps femoris. Correlations of palatability traits of one muscle to other muscles within an experimental unit were found to be low.